For instance, in hepatocellular carcinoma (HCC), SNHG3 regulates NEIL3 expression through transcription factor E2F1, implicating it as a potential diagnostic marker and therapeutic target [31]. This evidence concerns the gene E2F1 and hepatocellular carcinoma.